GelStat Corp. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes GelStat Migraine, Chews 2 Lose, All Natural Speed, and GelStat Speed. The company was founded on November 13, 1991 and is headquartered in Hunt Valley, MD.
Company profile
Ticker
GSAC
Exchange
Website
CEO
Robert Estey
Employees
Location
Fiscal year end
Industry (SIC)
Former names
Developed Technology Resource Inc
SEC CIK
Corporate docs
IRS number
900075732
GSAC stock data
Latest filings (excl ownership)
1-U
Current report (pursuant to Regulation A)
28 Nov 23
1-SA
Semiannual report
12 Oct 23
1-K
2022 FY
Annual report
10 May 23
1-U
Current report (pursuant to Regulation A)
7 Oct 22
1-SA
Semiannual report
3 Oct 22
1-K
2021 FY
Annual report
2 May 22
QUALIF
Notice of qualification
20 Dec 21
1-A/A
Offering $5M in Equity
15 Dec 21
CORRESP
Correspondence with SEC
15 Dec 21
1-A/A
Offering $5M in Equity
24 Nov 21
Latest ownership filings